ethambutol has been researched along with tacrolimus in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Egawa, H; Inomata, Y; Kiuchi, T; Okajima, H; Sano, K; Satomura, K; Tanaka, K; Uemoto, S; Uyama, S; Yamaoka, Y | 1 |
Hoshinaga, K; Ishikawa, K; Izumitani, M; Maruyama, T; Shiroki, R | 1 |
Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Nakamura, S; Takazono, T; Yanagihara, K | 1 |
Cohen, L; Guarner, J; Hunt, WR | 1 |
1 review(s) available for ethambutol and tacrolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for ethambutol and tacrolimus
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
Topics: Adult; Antibiotics, Antitubercular; Drug Interactions; Ethambutol; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Isoniazid; Liver Transplantation; Living Donors; Mycobacterium tuberculosis; Postoperative Complications; Rifampin; Streptomycin; Tacrolimus; Tuberculosis | 1996 |
Mycobacterium tuberculosis infection of bilateral cervical lymph nodes after renal transplantation.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neck; Rifampin; Tacrolimus; Tuberculosis, Lymph Node | 2001 |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.
Topics: Adalimumab; Administration, Oral; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Clarithromycin; Ethambutol; Glucocorticoids; Humans; Male; Mycobacterium; Mycobacterium Infections; Polychondritis, Relapsing; Rifampin; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
A novel presentation of Mycobacterium avium complex in a recipient of a lung transplant: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Graft Rejection; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prednisone; Pulmonary Fibrosis; Rifampin; Tacrolimus; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2017 |